Skip to main content

Table 4 The know groups comparison after treatment

From: Quality of life in patients with gastric cancer: translation and psychometric evaluation of the Iranian version of EORTC QLQ-STO22

 

Curative treatment

(n = 50)

Palliative treatment

(n = 55)

 
 

Mean (SD)

Mean (SD)

P*

EORTC QLQ-C30

Functioning scores**

Physical functioning

71.4 (21.8)

52.7 (23.6)

< 0.0001

Role functioning

74.4 (22.6)

61.2 (27.4)

0.02

Emotional functioning

66.2 (26.1)

56.9 (25.5)

0.08

Cognitive functioning

94.4 (12.8)

89.1 (17.7)

0.07

Social functioning

79.4 (16.1)

68.9 (26.8)

0.12

Global quality of life

50.1 (18.2)

38.4 (11.9)

0.003

Symptom scores***

Fatigue

40.0 (26.1)

54.3 (29.9)

0.01

Nausea & vomiting

15.9 (19.8)

33.3 (32.7)

0.01

Pain

25.9 (22.0)

43.3 (28.0)

0.001

Dyspnea

2.8 (9.4)

12.0 (20.1)

0.009

Insomnia

29.7 (31.6)

42.7 (35.5)

0.07

Appetite loss

10.6 (24.6)

27.7 (37.6)

0.009

Constipation

10.8 (23.3)

19.1 (27.5)

0.05

Diahrea

11.5 (21.3)

15.6 (28.5)

0.63

Financial difficulties

78.0 (32.1)

77.7 (33.3)

0.89

QLQ-STO22 scores***

Dysphagia

14.0 (23.0)

27.2 (28.6)

0.009

Stomach area pain

18.1 (19.3)

43.6 (26.3)

< 0.0001

Reflux

20.2 (21.8)

36.3 (24.5)

0.001

Eating restrictions

29.9 (15.1)

34.3 (15.4)

0.09

Anxiety

46.0 (34.7)

58.8 (32.3)

0.15

Dry mouth

38.5 (36.8)

53.6 (36.4)

0.05

Taste problem

24.0 (30.2)

35.8 (34.9)

0.11

Body image

25.0 (35.7)

38.3 (37.8)

0.25

Hair loss

39.6 (33.1)

51.4 (34.6)

0.14

  1. * P values derived from Mann-Whitney test
  2. ** Scores range from 0 to 100 with higher scores indicating better conditions.
  3. *** Scores range from 0 to 100 with higher scores indicating greater level of symptoms.